Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew I Milowsky

Showing results (41-50 of 205) with videos related to

Pageof 21
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|May 29, 2024
Can genitourinary cancer survivors understand quality of life (QoL) questionnaires? Assessing the readability of commonly used urologic oncology QoL instrumentsHannah Kay, Tracy L Rose, Matthew I Milowsky, et al.
Case Reports in Oncology|January 14, 2021
Secondary Immune Thrombocytopenia in Metastatic Renal Cell Carcinoma: A Case Report and Discussion of the LiteratureDillon C Cockrell, Raj S Kasthuri, Ersan Altun, et al.
The Journal of Urology|March 23, 2011
Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007)Katherine Mallin, Kevin A David, Peter R Carroll, et al.
The Journal of Urology|June 15, 2007
Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data BaseKevin A David, Matthew I Milowsky, Jamie Ritchey, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 14, 2020
Incidence and Prediction of Immune Checkpoint Inhibitor-related NephrotoxicityJonathan D Sorah, Tracy L Rose, Roshni Radhakrishna, et al.
Kidney Cancer (Clifton, Va.)|November 16, 2020
Trends in Initial Systemic Therapy for Elderly Patients with Metastatic Clear Cell Renal Cell CarcinomaChelsea K Osterman, Allison M Deal, Matthew I Milowsky, et al.
The Journal of Urology|April 20, 2010
Radical cystectomy in octogenarians--does morbidity outweigh the potential survival benefits?S Machele Donat, Timothy Siegrist, Angel Cronin, et al.
Expert Opinion on Therapeutic Targets|April 19, 2012
Novel molecular targets for the therapy of urothelial carcinomaBagi R P Jana, Matthew D Galsky, Noah M Hahn, et al.
Cancer|May 26, 2016
Sex disparities in use of chemotherapy and survival in patients with advanced bladder cancerTracy L Rose, Allison M Deal, Matthew E Nielsen, et al.
Anticancer Research|January 18, 2003
Detection of the p110 beta subunit of phosphatidylinositol 3-kinase complexed with neutral endopeptidaseRuoqian Shen, Matthew I Milowsky, Naoko Ozaki, et al.
Pageof 21

Showing results (41-50 of 205) with videos related to

Sort By:
Pageof 21
International Journal of Urology : Official Journal of the Japanese Urological Association|May 29, 2024
Can genitourinary cancer survivors understand quality of life (QoL) questionnaires? Assessing the readability of commonly used urologic oncology QoL instrumentsHannah Kay, Tracy L Rose, Matthew I Milowsky, et al.
Case Reports in Oncology|January 14, 2021
Secondary Immune Thrombocytopenia in Metastatic Renal Cell Carcinoma: A Case Report and Discussion of the LiteratureDillon C Cockrell, Raj S Kasthuri, Ersan Altun, et al.
The Journal of Urology|March 23, 2011
Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007)Katherine Mallin, Kevin A David, Peter R Carroll, et al.
The Journal of Urology|June 15, 2007
Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data BaseKevin A David, Matthew I Milowsky, Jamie Ritchey, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 14, 2020
Incidence and Prediction of Immune Checkpoint Inhibitor-related NephrotoxicityJonathan D Sorah, Tracy L Rose, Roshni Radhakrishna, et al.
Kidney Cancer (Clifton, Va.)|November 16, 2020
Trends in Initial Systemic Therapy for Elderly Patients with Metastatic Clear Cell Renal Cell CarcinomaChelsea K Osterman, Allison M Deal, Matthew I Milowsky, et al.
The Journal of Urology|April 20, 2010
Radical cystectomy in octogenarians--does morbidity outweigh the potential survival benefits?S Machele Donat, Timothy Siegrist, Angel Cronin, et al.
Expert Opinion on Therapeutic Targets|April 19, 2012
Novel molecular targets for the therapy of urothelial carcinomaBagi R P Jana, Matthew D Galsky, Noah M Hahn, et al.
Cancer|May 26, 2016
Sex disparities in use of chemotherapy and survival in patients with advanced bladder cancerTracy L Rose, Allison M Deal, Matthew E Nielsen, et al.
Anticancer Research|January 18, 2003
Detection of the p110 beta subunit of phosphatidylinositol 3-kinase complexed with neutral endopeptidaseRuoqian Shen, Matthew I Milowsky, Naoko Ozaki, et al.
Pageof 21